Role of dietary antioxidants in p53‐mediated cancer chemoprevention and tumor suppression

JPJ Merlin, HPV Rupasinghe… - … Medicine and Cellular …, 2021 - Wiley Online Library
Cancer arises through a complex interplay between genetic, behavioral, metabolic, and
environmental factors that combined trigger cellular changes that over time promote …

Regulation of TFEB activity and its potential as a therapeutic target against kidney diseases

W Zhang, X Li, S Wang, Y Chen, H Liu - Cell death discovery, 2020 - nature.com
The transcription factor EB (TFEB) regulates the expression of target genes bearing the
Coordinated Lysosomal Expression and Regulation (CLEAR) motif, thereby modulating …

[HTML][HTML] Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury

JY Cao, B Wang, TT Tang, Y Wen, ZL Li, ST Feng… - Theranostics, 2021 - ncbi.nlm.nih.gov
Mesenchymal stem cells-derived exosomes (MSC-exos) have attracted great interest as a
cell-free therapy for acute kidney injury (AKI). However, the in vivo biodistribution of MSC …

p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease

Z Ma, L Li, MJ Livingston, D Zhang, Q Mi… - The Journal of …, 2020 - Am Soc Clin Investig
Dysregulation of autophagy in diabetic kidney disease (DKD) has been reported, but the
underlying mechanism and its pathogenic role remain elusive. We show that autophagy was …

p53 deacetylation alleviates sepsis-induced acute kidney injury by promoting autophagy

M Sun, J Li, L Mao, J Wu, Z Deng, M He, S An… - Frontiers in …, 2021 - frontiersin.org
Recent studies have shown that autophagy upregulation can attenuate sepsis-induced
acute kidney injury (SAKI). The tumor suppressor p53 has emerged as an autophagy …

Teprasiran, a small interfering RNA, for the prevention of acute kidney injury in high-risk patients undergoing cardiac surgery: a randomized clinical study

M Thielmann, D Corteville, G Szabo, M Swaminathan… - Circulation, 2021 - Am Heart Assoc
Background: Acute kidney injury (AKI) affects up to 30% of patients undergoing cardiac
surgery, leading to increased in-hospital and long-term morbidity and mortality. Teprasiran is …

Kim-1 targeted extracellular vesicles: a new therapeutic platform for RNAi to treat AKI

TT Tang, B Wang, ZL Li, Y Wen, ST Feng… - Journal of the …, 2021 - journals.lww.com
Background AKI is a significant public health problem with high morbidity and mortality.
Unfortunately, no definitive treatment is available for AKI. RNA interference (RNAi) provides …

Modified chitosan for effective renal delivery of siRNA to treat acute kidney injury

W Tang, S Panja, CM Jogdeo, S Tang, L Ding, A Yu… - Biomaterials, 2022 - Elsevier
Acute kidney injury (AKI) is characterized by a sudden decrease in renal function and
impacts growing number of people worldwide. RNA interference (RNAi) showed potential to …

A-lipoic acid alleviates folic acid-induced renal damage through inhibition of ferroptosis

X Li, YU Zou, YY Fu, J Xing, KY Wang, PZ Wan… - Frontiers in …, 2021 - frontiersin.org
Folic acid (FA)-induced acute kidney injury (AKI) is characterized by the disturbance of redox
homeostasis, resulting in massive tubular necrosis and inflammation. Α-lipoic acid (LA), as …

Snai1-induced partial epithelial–mesenchymal transition orchestrates p53–p21-mediated G2/M arrest in the progression of renal fibrosis via NF-κB-mediated …

R Qi, J Wang, Y Jiang, Y Qiu, M Xu, R Rong… - Cell Death & …, 2021 - nature.com
Renal fibrosis is the common feature of all progressive kidney diseases and exerts great
burden on public health worldwide. The maladaptive repair mechanism of tubular epithelial …